News
In a paper published on June 12 in the journal Cell Reports, UC Davis researchers show that a wide range of psychedelic drugs, including LSD and MDMA, impact the structure and function of neurons ...
Hosted on MSN7mon
Discovery reveals how low-dose ketamine, a 'lifesaving' drug for major depression, alleviates symptoms withing hoursMore information: Jamie A. Abbott et al, Allosteric inhibition of NMDA receptors by low dose ketamine, Molecular Psychiatry (2024). DOI: 10.1038/s41380-024-02729-9 Provided by University at Buffalo ...
Behavioral studies also hint at the similarities between psychedelics and ketamine. In another recent paper published in ACS Chemical Neuroscience, Olson’s group showed that DMT treatment enabled rats ...
Since this observation was published in the early 2000s, ketamine clinics, where the drug is administered intravenously to treat depression, have been established in cities nationwide. But just how ...
Ketamine has been used since the 1960s as an anesthetic, but in 2000, the first trial of far lower doses of ketamine proved its rapid efficacy in treating major depression and suicidal ideation.
Since this observation was published in the early 2000s, ketamine clinics, where the drug is administered intravenously to treat depression, have been established in cities nationwide. But just how ...
But, the channels of the receptor can be blocked by a molecule. Blocking by magnesium helps to naturally regulate ion flow. Ketamine, however, is an especially effective blocker. Blocking slows the ...
A World Health Organization Essential Medicine, ketamine is widely used at varying doses for sedation, pain control, general anesthesia and as a therapy for treatment-resistant depression. While ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results